Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nat Commun ; 15(1): 1860, 2024 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-38424057

RESUMEN

Cyclic dimeric guanosine monophosphate (c-di-GMP) serves as a bacterial second messenger that modulates various processes including biofilm formation, motility, and host-microbe symbiosis. Numerous studies have conducted comprehensive analysis of c-di-GMP. However, the mechanisms by which certain environmental signals such as iron control intracellular c-di-GMP levels are unclear. Here, we show that iron regulates c-di-GMP levels in Pseudomonas aeruginosa by modulating the interaction between an iron-sensing protein, IsmP, and a diguanylate cyclase, ImcA. Binding of iron to the CHASE4 domain of IsmP inhibits the IsmP-ImcA interaction, which leads to increased c-di-GMP synthesis by ImcA, thus promoting biofilm formation and reducing bacterial motility. Structural characterization of the apo-CHASE4 domain and its binding to iron allows us to pinpoint residues defining its specificity. In addition, the cryo-electron microscopy structure of ImcA in complex with a c-di-GMP analog (GMPCPP) suggests a unique conformation in which the compound binds to the catalytic pockets and to the membrane-proximal side located at the cytoplasm. Thus, our results indicate that a CHASE4 domain directly senses iron and modulates the crosstalk between c-di-GMP metabolic enzymes.


Asunto(s)
Proteínas Bacterianas , GMP Cíclico/análogos & derivados , Proteínas de Escherichia coli , Inosina Monofosfato/análogos & derivados , Tionucleótidos , Proteínas Bacterianas/metabolismo , Pseudomonas aeruginosa/metabolismo , Microscopía por Crioelectrón , Proteínas de Escherichia coli/metabolismo , GMP Cíclico/metabolismo , Biopelículas , Regulación Bacteriana de la Expresión Génica
2.
Environ Pollut ; 343: 123175, 2024 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-38142031

RESUMEN

A declining trend in Indian summer monsoon precipitation (ISMP) in the latter half of the 20th century is a scientifically challenging and societally relevant research issue. Heavy aerosol loading over India is one of the key factors in modulating the ISMP. Using the state-of-the-state-of-the-art chemistry-climate model, ECHAM6-HAMMOZ, the impacts of South Asian anthropogenic sulfate aerosols on the Indian summer monsoon precipitation were investigated against: (1) 2010 La Niña (excess monsoon), (2) 2015 El Niño (deficit monsoon) in comparison to (3) normal monsoon 2016. Sensitivity simulations were designed with 48% enhancement in South Asian SO2 emissions based on a trend estimated from Ozone Monitoring Instrument (OMI) satellite observations during 2006-2017. The model simulations showed that sulfate aerosols reduce ISMP by 27.5%-43.3 %, while simulations without sulfate loading enhanced ISMP by 23% in 2010 La Niña and reduction by 35% in 2015 El Niño. This paper reports that sulfate aerosols loading over India reduce precipitation by aerosol-induced direct and indirect effects by inducing atmospheric cooling, weakening in the convection, and reduction in moisture transport to Indian landmass. This paper emphasizes the necessity of alternate use of energy to reduce sulfate aerosol emissions to solve water issues in South Asia.


Asunto(s)
Contaminantes Atmosféricos , Inosina Monofosfato/análogos & derivados , Sulfatos , Tionucleótidos , Contaminantes Atmosféricos/análisis , Estaciones del Año , Aerosoles/análisis
3.
J Am Pharm Assoc (2003) ; 61(4S): S105-S117, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33812781

RESUMEN

OBJECTIVES: This study sought to characterize users' perceptions of, and identify the average time needed to complete a newly abbreviated version of the Institute for Safe Medication Practices Medication Safety Self Assessment for Community and Ambulatory Pharmacy (MSSA-CAP). METHODS: This study took place within a large, national, nonprofit, faith-based health system. An abbreviated version of ISMP's MSSA-CAP was developed through an iterative process by researchers and the health system's medication safety officers (MSOs, i.e., the assessment tool's 'users'). Retained items included those with nonoverlapping (1) bolded or keywords; (2) "quick asks," answerable without external information; or (3) were relevant to community pharmacy practice (i.e., nonambulatory care-specific). During site visits, MSOs assessed the organization's community pharmacies with the abbreviated tool. Users completed pre- and post-visit surveys asking their perceptions of and time spent using the full and abbreviated versions of the MSSA-CAP. Results were analyzed using descriptive statistics. RESULTS: Sixty of the original MSSA-CAP's 216 items were retained. Between August to December 2019, six MSO users assessed 59 community pharmacies across 10 states with the abbreviated assessment tool. On the average, users reported needing 86.1 ± 35.4 minutes to complete the abbreviated assessment. Sixty-seven percent of users agreed or strongly agreed that the abbreviated assessment was of a good length, compared with only 17% for the original full assessment. Collectively, assessed community pharmacies scored highest on MSSA-CAP items related to Physical Environment and Prescription Labels, and lowest on Hard Stops and Proactive Risk Assessments. CONCLUSION: Streamlining items in medication safety assessment tools may be useful in overcoming time barriers to implementation in community pharmacies.


Asunto(s)
Servicios Comunitarios de Farmacia , Servicios Farmacéuticos , Farmacias , Humanos , Inosina Monofosfato/análogos & derivados , Percepción , Autoevaluación (Psicología) , Tionucleótidos
4.
Microbiol Res ; 232: 126375, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31783262

RESUMEN

Effectors secreted by microbes contribute to pathogen virulence and/or avirulence on host plants in the interaction of plants and microbes. Also, the effector repertoire determines the host specificity of a pathogen. Fusarium oxysporum f. sp. cubense (Foc) is the causal agent of banana wilt; however, knowledge about Foc effector genes is very limited. In this study, genome-wide effector gene identification was performed in Foc race 1 (Foc 1) and Foc race 4 (Foc 4) based on the context association between the effector genes and the transposable element mimp. A total of 20 candidate effector genes were identified, of which 3 were Foc 1-specific, 6 were Foc 4-specific, and 11 were present in both Foc 1 and Foc 4. Most genes (14 out of 20) showed a significant transcriptional burst in planta compared with in-culture conditions, from more than 10-fold to 1,617-fold, and at the highest 32,725-fold. In addition to Foc 1- and Foc 4-specific genes, the genes Foc 283, Foc 495, and Foc 594 also exhibited transcriptional race specificity. Sixteen of the twenty genes were predicted to have a signal peptide, nine genes might encode real effectors predicted by EffectorP 2.0, and eight genes had predicted motifs. To validate the pathogenicity of the candidate effector genes, we generated knockout mutant and complementants of the gene Foc 1324 and tested their virulence on banana plants. The results showed that Foc 1324 was a virulent factor and required for the pathogenicity of Foc 4.


Asunto(s)
Proteínas Fúngicas/genética , Fusarium/genética , Inosina Monofosfato/análogos & derivados , Enfermedades de las Plantas/genética , Fusarium/patogenicidad , Perfilación de la Expresión Génica , Regulación Fúngica de la Expresión Génica , Técnicas de Inactivación de Genes , Genoma Fúngico , Musa/microbiología , Enfermedades de las Plantas/microbiología , Factores de Transcripción/genética , Virulencia/genética
5.
Nucleic Acids Res ; 45(20): 11515-11524, 2017 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-29036687

RESUMEN

Nucleotide quality surveillance enzymes play important roles in human health, by detecting damaged molecules in the nucleotide pool and deactivating them before they are incorporated into chromosomal DNA or adversely affect metabolism. In particular, deamination of adenine moiety in (deoxy)nucleoside triphosphates, resulting in formation of (d)ITP, can be deleterious, leading to DNA damage, mutagenesis and other harmful cellular effects. The 21.5 kDa human enzyme that mitigates this damage by conversion of (d)ITP to monophosphate, ITPA, has been proposed as a possible therapeutic and diagnostic target for multiple diseases. Measuring the activity of this enzyme is useful both in basic research and in clinical applications involving this pathway, but current methods are nonselective and are not applicable to measurement of the enzyme from cells or tissues. Here, we describe the design and synthesis of an ITPA-specific chimeric dinucleotide (DIAL) that replaces the pyrophosphate leaving group of the native substrate with adenosine triphosphate, enabling sensitive detection via luciferase luminescence signaling. The probe is shown to function sensitively and selectively to quantify enzyme activity in vitro, and can be used to measure the activity of ITPA in bacterial, yeast and human cell lysates.


Asunto(s)
Adenosina Trifosfato/química , Pruebas de Enzimas/métodos , Colorantes Fluorescentes/química , Inosina Monofosfato/análogos & derivados , Mediciones Luminiscentes/métodos , Pirofosfatasas/metabolismo , Extractos Celulares/química , Línea Celular Tumoral , ADN/genética , Daño del ADN/genética , Desaminación , Células HeLa , Humanos , Inosina Monofosfato/química , Pirofosfatasas/genética , Interferencia de ARN , ARN Interferente Pequeño/genética
6.
Chem Senses ; 42(5): 393-404, 2017 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-28334294

RESUMEN

The heterodimeric T1R1 + T1R3 receptor is considered critical for normal signaling of L-glutamate and 5'-ribonucleotides in the oral cavity. However, some taste-guided responsiveness remains in mice lacking one subunit of the receptor, suggesting that other receptors are sufficient to support some behaviors. Here, mice lacking both receptor subunits (KO) and wild-type (WT, both n = 13) mice were tested in a battery of behavioral tests. Mice were trained and tested in gustometers with a concentration series of Maltrin-580, a maltodextrin, in a brief-access test (10-s trials) as a positive control. Similar tests followed with monosodium glutamate (MSG) with and without the ribonucleotide inosine 5'-monophosphate (IMP), but always in the presence of the epithelial sodium channel blocker amiloride (A). Brief-access tests were repeated following short-term (30-min) and long-term (48-h) exposures to MSG + A + IMP and were also conducted with sodium gluconate replacing MSG. Finally, progressive ratio tests were conducted with Maltrin-580 or MSG + A + IMP, to assess appetitive behavior while minimizing satiation. Overall, MSG generated little concentration-dependent responding in either food-restricted WT or KO mice, even in combination with IMP. However, KO mice licked less to the amino acid stimuli, a measure of consummatory behavior in the brief-access tests. In contrast, both groups initiated a similar number of trials and had a similar breakpoint in the progressive ratio task, both measures of appetitive (approach) behavior. Collectively, these results suggest that while the T1R1 + T1R3 receptor is necessary for consummatory responding to MSG (+IMP), other receptors are sufficient to maintain appetitive responding to this "umami" stimulus complex in food-restricted mice.


Asunto(s)
Ácido Glutámico/farmacología , Inosina Monofosfato/análogos & derivados , Filosofía , Receptores Acoplados a Proteínas G/deficiencia , Gusto/efectos de los fármacos , Gusto/fisiología , Animales , Femenino , Ácido Glutámico/administración & dosificación , Inosina Monofosfato/administración & dosificación , Inosina Monofosfato/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados
7.
Spectrochim Acta A Mol Biomol Spectrosc ; 151: 679-86, 2015 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-26163792

RESUMEN

Analogues of intermediates involved in the purine salvage pathway can be exploited as potential drug molecules against enzymes of protozoan parasites. To develop such analogues we need knowledge of the solution structures, predominant tautomer at physiological pH and protonation-state of the corresponding natural ligand. In this regard, we have employed ultraviolet resonance Raman spectroscopy (UVRR) in combination with density functional theory (DFT) to study the solution structures of two relatively unexplored intermediates, 6-phosphoryl IMP (6-pIMP) and succinyl adenosine-5'-monophosphate (sAMP), of purine salvage pathway. These molecules are intermediates in a two step enzymatic process that converts inosine-5'-monpophosphate (IMP) to adenosine-5'-monophosphate (AMP). Experimental data on the molecular structure of these ligands is lacking. We report UVRR spectra of these two ligands, obtained at an excitation wavelength of 260 nm. Using isotope induced shifts and DFT calculations we assigned observed spectra to computed normal modes. We find that sAMP exists as neutral species at physiological pH and the predominant tautomer in solution bears proton at N10 position of purine ring. Though transient in solution, 6-pIMP is captured in the enzyme-bound form. This work provides the structural information of these ligands in solution state at physiological pH. We further compare these structures with the structures of AMP and IMP. Despite the presence of similar purine rings in AMP and sAMP, their UVRR spectra are found to be very different. Similarly, though the purine ring in 6-pIMP resembles that of IMP, UVRR spectra of the two molecules are distinct. These differences in the vibrational spectra provide direct information on the effects of exocyclic groups on the skeletal structures of these molecules. Our results identify key bands in the vibrational spectra of these ligands which may serve as markers of hydrogen bonding interactions upon binding to the active-sites of enzymes.


Asunto(s)
Purinas/química , Adenosina Monofosfato/análogos & derivados , Adenosina Monofosfato/química , AMP Cíclico/análogos & derivados , AMP Cíclico/química , Concentración de Iones de Hidrógeno , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/química , Ligandos , Estructura Molecular , Soluciones , Espectrometría Raman/métodos , Rayos Ultravioleta , Vibración
8.
Chem Rec ; 15(2): 511-23, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25707449

RESUMEN

Cyclic adenosine 5'-diphosphate ribose (cADPR) is a second messenger in the Ca(2+) signaling pathway. To elucidate its molecular mechanism in calcium release, a series of cADPR analogues with modification on ribose, nucleobase, and pyrophosphate have been investigated. Among them, the analogue with the modification of the northern ribose by ether linkage substitution (cIDPRE) exhibits membrane-permeate Ca(2+) agonistic activity in intact HeLa cells, human T cells, mouse cardiac myocytes and neurosecretory PC12 cell lines; thus, cIDPRE and coumarin-caged cIDPRE are valuable probes to investigate the cADPR-mediated Ca(2+) signal pathway.


Asunto(s)
Señalización del Calcio , Calcio/metabolismo , ADP-Ribosa Cíclica/química , Sondas Moleculares/química , Miocitos Cardíacos/metabolismo , Animales , Cumarinas/química , ADP-Ribosa Cíclica/síntesis química , Células HeLa , Humanos , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/química , Células Jurkat , Ratones , Imitación Molecular , Sondas Moleculares/síntesis química , Miocitos Cardíacos/citología , Miocitos Cardíacos/efectos de los fármacos , Células PC12 , Ratas , Relación Estructura-Actividad
9.
Chem Commun (Camb) ; 47(33): 9462-4, 2011 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-21785757

RESUMEN

A concise method for the formation of cyclopyrophosphate of cIDPRE as well as sulfur and selenium-substituted pyrophosphate cIDPRE analogues (P(1)(S)-cIDPRE, P(1)(Se)-cIDPRE, P(2)(S)-cIDPRE and P(2)(Se)-cIDPRE) was reported and one of the P(S)-diastereoisomers, P(1)(S)-cIDPRE-1, is a novel membrane-permeant cADPR antagonist.


Asunto(s)
ADP-Ribosa Cíclica/análogos & derivados , Difosfatos/química , Bloqueadores de los Canales de Calcio/síntesis química , Bloqueadores de los Canales de Calcio/química , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/síntesis química , Inosina Monofosfato/química , Conformación Molecular , Canal Liberador de Calcio Receptor de Rianodina/química , Canal Liberador de Calcio Receptor de Rianodina/metabolismo , Selenio/química , Estereoisomerismo , Azufre/química
10.
J Am Chem Soc ; 133(21): 8059-61, 2011 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-21545145

RESUMEN

Standard molecular mechanics (MM) force fields predict a nearly linear decrease in hydration free energy with each successive addition of a methyl group to ammonia or acetamide, whereas a nonadditive relationship is observed experimentally. In contrast, the non-additive hydration behavior is reproduced directly using a quantum mechanics (QM)/MM-based free-energy perturbation (FEP) method wherein the solute partial atomic charges are updated at every window. Decomposing the free energies into electrostatic and van der Waals contributions and comparing the results with the corresponding free energies obtained using a conventional FEP method and a QM/MM method wherein the charges are not updated suggests that inaccuracies in the electrostatic free energies are the primary reason for the inability of the conventional FEP method to predict the experimental findings. The QM/MM-based FEP method was subsequently used to evaluate inhibitors of the diabetes drug target fructose-1,6-bisphosphatase adenosine 5'-monophosphate and 6-methylamino purine riboside 5'-monophosphate. The predicted relative binding free energy was consistent with the experimental findings, whereas the relative binding free energy predicted using the conventional FEP method differed from the experimental finding by an amount consistent with the overestimated relative solvation free energies calculated for alkylamines. Accordingly, the QM/MM-based FEP method offers potential advantages over conventional FEP methods, including greater accuracy and reduced user input. Moreover, since drug candidates often contain either functionality that is inadequately treated by MM (e.g., simple alkylamines and alkylamides) or new molecular scaffolds that require time-consuming development of MM parameters, these advantages could enable future automation of FEP calculations as well as greatly increase the use and impact of FEP calculations in drug discovery.


Asunto(s)
Acetamidas/química , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Inhibidores Enzimáticos/uso terapéutico , Fructosa-Bifosfatasa/antagonistas & inhibidores , Metilaminas/química , Adenosina Monofosfato/química , Simulación por Computador , Humanos , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/química , Simulación de Dinámica Molecular , Teoría Cuántica , Termodinámica
11.
Org Biomol Chem ; 8(20): 4705-15, 2010 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-20740240

RESUMEN

A convenient trifluoromethylation method was firstly applied to the synthesis of 8- CF(3)-purine nucleosides. On the basis of this method, new protection and deprotection strategies were developed for the successful synthesis of the trifluoromethylated cyclic-ADP-ribose mimic, 8-CF(3)-cIDPRE 1. Using intact, fura-2-loaded Jurkat T cells compound 1 and 2',3'-O-isopropylidene 8-CF(3)-cIDPRE 14 were characterized as membrane-permeant cADPR agonists. Contrary to the 8-substituted cADPR analogues that mainly act as antagonists of cADPR in cells, 8-substituted cIDPRE derivatives were shown to be Ca(2+) mobilizing agonists. Here we report that even compound 1, the 8-substituted cIDPRE with the strong electron withdrawing CF(3) group, behaves as an agonist in T cells. Interestingly, also the partially protected 2',3'-O-isopropylidene 8-CF(3)-cIDPRE activated Ca(2+) signaling indicating only a minor role for the hydroxyl groups of the southern ribose of cADPR for its biological activity. To our knowledge 8-CF(3)-cIDPRE 1 is the first reported fluoro substituted cADPR mimic and 8-CF(3)-cIDPRE 1 and compound 14 are promising molecular probes for elucidating the mode of action of cADPR.


Asunto(s)
Calcio/metabolismo , ADP-Ribosa Cíclica/análogos & derivados , Linfocitos T/metabolismo , Adenosina Difosfato Ribosa/química , ADP-Ribosa Cíclica/síntesis química , ADP-Ribosa Cíclica/química , Humanos , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/química , Relación Estructura-Actividad
12.
Antiviral Res ; 71(1): 64-8, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16581141

RESUMEN

An inbred murine model (BALB/c) was utilized to assess the protective effect of the immunomodulator methyl inosine 5'-monophosphate (MIMP) against infection with influenza A/PR/8/34 (H1N1) virus. Contrary to the data reported for outbred mice (NMRI) infected with the aerosolized virus (Masihi, Hadden, 2003. J. Int. Immunopharmacol. 3, 1205-1215), there were no improvements in the outcomes of infection in the inbred animals treated with MIMP intranasally 1 day before the challenge and/or orally after the challenge for 5 days (up to 10 mg/kg/day). Nevertheless, complete protection against lethality was afforded by the treatment with the neuraminidase inhibitor peramivir given once daily for 5 days after the challenge (10 mg/kg/day). We speculate that the rapid progression of the disease in inbred mice caused by the intranasal challenge may render the MIMP-treatment ineffective. Our results emphasize the need for careful consideration of murine strains and routes of virus challenge in the design of experiments utilizing lethal influenza virus infection.


Asunto(s)
Antivirales/farmacología , Ciclopentanos/farmacología , Guanidinas/farmacología , Subtipo H1N1 del Virus de la Influenza A/crecimiento & desarrollo , Inosina Monofosfato/análogos & derivados , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Infecciones por Orthomyxoviridae/virología , Ácidos Carbocíclicos , Factores de Edad , Animales , Peso Corporal , Modelos Animales de Enfermedad , Femenino , Inosina Monofosfato/farmacología , Ratones , Ratones Endogámicos BALB C
13.
J Med Chem ; 47(23): 5674-82, 2004 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-15509166

RESUMEN

N1-[(5' '-O-Phosphorylethoxy)methyl]-5'-O-phosphorylinosine 5',5''-cyclicpyrophosphate (cIDPRE 2a) and the 8-substituted derivatives 8-bromo-, 8-azido-, 8-amino-, and 8-Cl-cIDPRE (2b-e) were synthesized from N1-[(5''-acetoxyethoxy)methyl]-2',3'-O-isopropylideneinosine (5) in good yields. The pharmacological activities of cIDPRE and the 8-substituted derivatives (2a-e) were analyzed in intact and permeabilized human Jurkat T-lymphocytes. The results indicate that cIDPRE permeates the plasma membrane, releases Ca2+ from an intracellular, cADPR-sensitive Ca2+ store, and subsequently initiates Ca2+ release-activated Ca2+ entry. The Ca(2+)-releasing activity of cIDPRE was confirmed directly in permeabilized cells. Using time-resolved confocal Ca2+ imaging at the single cell level, the development of global Ca2+ signals starting from local small Ca2+ signals evoked by cIDPRE was observed. 8-N3-cIDPRE 2c and 8-NH2-cIDPRE 2d were similarly effective in their agonistic activity as compared to cIDPRE 2a, showing almost indistinguishable concentration-response curves for 2a, 2c, and 2d and very similar kinetics of Ca2+ signaling. In contrast, the halogenated derivatives 8-Br- and 8-Cl-cIDPRE (2b and 2e) did not significantly elevate [Ca2+]i. Therefore, cIDPRE 2a, 8-N3-cIDPRE 2c, and 8-NH2-cIDPRE 2d are novel membrane permeant cADPR mimic and may provide important novel tools to study cADPR-mediated Ca2+ signaling in intact cells.


Asunto(s)
Adenosina Difosfato Ribosa/química , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/síntesis química , Señalización del Calcio/efectos de los fármacos , Membrana Celular/metabolismo , Humanos , Inosina Monofosfato/química , Inosina Monofosfato/farmacocinética , Inosina Monofosfato/farmacología , Células Jurkat , Imitación Molecular , Permeabilidad , Relación Estructura-Actividad
14.
Chembiochem ; 5(11): 1543-9, 2004 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-15515088

RESUMEN

DNA is the ultimate target of platinum-based anticancer therapy. Since the N7 of guanine is known to be the major binding site of cisplatin and its analogues, adduct formation with model nucleotides, especially 2'-deoxyguanosine 5'-monophosphate (dGMP), has been studied in detail. During the last few years a coupled capillary eletrophoresis/electrospray-ionization mass spectrometry (CE/ESI-MS) method has been advantageously used in order to separate and identify platinum adducts with nucleotides in submillimolar concentrations in aqueous solutions. Beside the bisadduct, [Pt(NH(3))(2)(dNMP)(2)](2-) (NMP=2'-deoxynucleoside 5'-monophosphate), and the well-known monochloro and monohydroxo adducts, [Pt(NH(3))(2)Cl(dNMP)](-) and [Pt(NH(3))(2)(dNMP)OH](-), respectively, a third kind of monoadduct species with a composition of [Pt(NH(3))(2)(dNMP)](-) can be separated by CE and detected through the m/z values measured with ESI-MS. Different experimental setups indicate the existence of an O(6)-N7 chelate, whereas the formation of N7-alphaPO(4) macrochelates or dinuclear species is unlikely. Additionally, offline MS experiments with 2'-deoxyguanosine (dG) and stabilization of the controversially discussed O(6)-N7 chelate by oxidation with hydrogen peroxide support the assumption of the existence of O(6)-N7 chelation.


Asunto(s)
Cisplatino/química , Aductos de ADN/química , Guanosina Monofosfato/química , Inosina Monofosfato/análogos & derivados , Nucleósidos/química , Nucleótidos/química , Compuestos Organoplatinos/química , Aductos de ADN/análisis , Nucleótidos de Desoxiguanina/química , Electroforesis Capilar/métodos , Inosina Monofosfato/química , Estructura Molecular , Espectrometría de Masa por Ionización de Electrospray/métodos
16.
Int Immunopharmacol ; 3(8): 1177-86, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12860173

RESUMEN

Methyl inosine 5'-monophosphate (MIMP) was designed and synthesized in an endeavor to generate compounds with immunostimulatory activity based on the precedent of purines, particularly inosine playing a central role in the development and function of the immune system. This review will summarize the immune-enhancing effects of MIMP on a variety of immunological responses both in vitro and in vivo. Among these studies, MIMP displays protective effects in several in vivo models of infectious disease following administration by one of several routes including oral. Furthermore, MIMP enhanced responses to Hepatitis B and influenza vaccines. Vaccination represents an extremely powerful tool for combating a variety of diseases, perhaps even cancer. However, to date, vaccines have been limited by their inability to produce cell-mediated responses and by the low immunogenicity of soluble/subunit antigens. In addition, there are difficulties in eliciting sufficient responses in immunocompromised individuals, which includes the elderly, due to the natural immunosenescence that occurs with aging. The data described here suggest that MIMP could be used to overcome some of these limitations. The application of MIMP as an adjuvant to the influenza vaccine, focusing on the elderly, at-risk populations will be discussed in more detail; however, several other bacterial and viral vaccine and/or disease targets merit further consideration.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Enfermedades Transmisibles/inmunología , Inmunización , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/uso terapéutico , Linfocitos T/inmunología , Envejecimiento/inmunología , Animales , Enfermedades Transmisibles/tratamiento farmacológico , Humanos , Linfocitos T/efectos de los fármacos
17.
Bioorg Med Chem Lett ; 13(4): 645-7, 2003 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-12639549

RESUMEN

Inosine 5'-monophosphate dehydrogenase (IMPDH; EC 1.1.1.205) isolated from Escherichia coli B3 cells was strongly inhibited by 2-[2-(Z)-fluorovinyl]inosine 5'-monophosphate (2-FVIMP). Inhibition of IMPDH appears to be irreversible with k(inact) and K(i) values of 0.0269 s(-1) and 1.11 microM, respectively.


Asunto(s)
IMP Deshidrogenasa/antagonistas & inhibidores , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/farmacología , Proteínas de Escherichia coli , Cinética , Desnaturalización Proteica/efectos de los fármacos , Renaturación de Proteína/efectos de los fármacos
18.
J Med Chem ; 45(24): 5340-52, 2002 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-12431061

RESUMEN

Cyclic ADP-ribose (cADPR) is not only a potent endogenous calcium modulator but also a second messenger. However, studies on the mechanism of cADPR action were limited due to its instability and lack of available structural modifications in the N1-glyosyl unit of cADPR. In the present work, a series of N1-glycosyl mimics with different configurational glycosyls or an ether strand were designed and synthesized mimicking the furanose ring. S(N)2 substitutions were carried out between the protected inosine and glycosyl triflates to form the N1-glycosylinosine derivatives, accompanied with some O6-glycosyl-substituted as side products. The intramolecular cyclization was followed the strategy described by Matsuda et al. It was found that the 8-unsubstituted substrate could also be used to construct the intramolecular cyclic pyrophosphate. The activities of N1-glycosyl-substituted cADPR mimics were evaluated by induced Ca2+ release in rat brain microsomes and HeLa cells. It was found that the configuration of the N1-glycosyl moiety in cADPR is not a critical structural factor for retaining the activity of mobilizing Ca2+ release. More interestingly, the N1-acyclic analogue 6 exhibited strong activity by inducing Ca2+ release in both rat brain microsomes and HeLa cells. It constitutes a useful tool for further studies.


Asunto(s)
Calcio/metabolismo , ADP-Ribosa Cíclica/análogos & derivados , ADP-Ribosa Cíclica/síntesis química , Inosina Monofosfato/síntesis química , Animales , Encéfalo/metabolismo , Encéfalo/ultraestructura , Cristalografía por Rayos X , ADP-Ribosa Cíclica/química , ADP-Ribosa Cíclica/farmacología , Ciclización , Células HeLa , Humanos , Técnicas In Vitro , Inosina Difosfato/síntesis química , Inosina Difosfato/química , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/química , Inosina Monofosfato/farmacología , Microsomas/metabolismo , Imitación Molecular , Ratas , Ratas Sprague-Dawley , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Relación Estructura-Actividad
19.
Bioorg Med Chem ; 10(11): 3615-8, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12213477

RESUMEN

A new enzyme-mediated synthesis of 2-vinylinosine, a compound with broad-spectrum RNA antiviral activity, is described. In order to understand the mechanism of action of this compound, we synthesized its monophosphate and investigated the behavior of that compound toward the enzyme, inosine monophosphate dehydrogenase (IMPDH), a key enzyme involved in the biosynthesis of nucleotides. 2-Vinylinosine monophosphate is a potent inhibitor of IMPDH with a K(i) of 3.98 microM (k(inact)=2.94 x 10(-2) s(-1)). The antiviral activity of 2-vinylinosine may be explained by its cellular conversion to the monophosphate through the sequential action of PNP and HGPRT and subsequent inhibition of IMPDH by the cellularly produced 2-vinylinosine 5'-monophosphate.


Asunto(s)
Antivirales/farmacología , Inhibidores Enzimáticos/farmacología , IMP Deshidrogenasa/antagonistas & inhibidores , Inosina Monofosfato/síntesis química , Inosina Monofosfato/farmacología , Antivirales/síntesis química , Cristalografía por Rayos X , Inhibidores Enzimáticos/síntesis química , Escherichia coli/efectos de los fármacos , Escherichia coli/enzimología , IMP Deshidrogenasa/aislamiento & purificación , Indicadores y Reactivos , Inosina Monofosfato/análogos & derivados , Cinética , Desnaturalización Proteica , Renaturación de Proteína , Virus ARN/efectos de los fármacos , ARN Viral/biosíntesis , ARN Viral/genética
20.
Int Immunopharmacol ; 2(6): 835-41, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12095174

RESUMEN

Methyl inosine monophosphate (MIMP) is a novel thymomimetic purine immunomodulator capable of enhancing a wide variety of immune responses. Intravenous (i.v.) administration of MIMP 1 day prior to influenza virus infection could confer partial protection and significantly increase the mean survival of treated mice. Intranasal (i.n.) administration of MIMP improved survival rates and incorporation of MIMP in squalane-saline emulsion 1 day prior to or 1 h after influenza infection conferred complete protection. Mice administered MIMP had reduced levels of lung virus and lower titers of circulating serum hemagglutination-inhibition (HI) antibodies. Complete survival and reduction of viral load after influenza challenge infection suggests effective stimulation by MIMP of protective responses against influenza virus.


Asunto(s)
Virus de la Influenza A , Inosina Monofosfato/análogos & derivados , Inosina Monofosfato/uso terapéutico , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Infecciones por Orthomyxoviridae/prevención & control , Aerosoles , Animales , Femenino , Virus de la Influenza A/efectos de los fármacos , Inosina Monofosfato/farmacología , Ratones , Infecciones por Orthomyxoviridae/sangre , Infecciones por Orthomyxoviridae/mortalidad , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...